BioSpace News Archive

BioVaxys Technology Corp. is pleased to announce that Dasha Enenko has been appointed as its Chief Financial Officer (“CFO”).

Outset Medical, Inc. today announced that it will release financial results for the first quarter of 2023 after the close of trading on Wednesday, May 3, 2023.

Naveris, Inc., a leader in molecular diagnostics for viral cancers, today announced the launch of the DART 2.0 prospective clinical trial (NCT05541016) by Mayo Clinic.

NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic and medical imaging applications, has announced the promotion of Jason Vinyard, MBA, MHA, to Vice President, Business Development, Therapeutic Technologies.

ONWARD Medical N.V., the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, announced that management will attend the following conferences in the upcoming weeks.

Aspect Biosystems and Novo Nordisk A/S announced a collaboration, development, and licence agreement to develop bioprinted tissue therapeutics designed to replace, repair, or supplement biological functions inside the body with the aim of delivering a new class of truly disease-modifying treatments for diabetes and obesity.